Author(s): Mohammad Ali Roozegar, Hassan Nourmohammadi, Mohammadreza Havasian, Hossein Seidkhani, Solmaz Jamdar

Email(s): dr.solmazjamdar@gmail.com

DOI: 10.52711/0974-360X.2022.00931   

Address: Mohammad Ali Roozegar1, Hassan Nourmohammadi2, Mohammadreza Havasian3, Hossein Seidkhani4, Solmaz Jamdar5*
1Department of Periodontology, Faculty of Dentistry, Ilam University of Medical Sciences, Ilam, Iran.
2Department of Internal Medicine, Shahid-Mostafa Khomeini hospital, Ilam University of Medical Sciences, Ilam, Iran.
3Student Research of Committee, Alborz University of Medical Sciences, Karaj, Iran.
4Department of Biostatistics, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran.
5Faculty of Dentistry, Alborz University of Medical Sciences, Karaj, Iran.
*Corresponding Author

Published In:   Volume - 15,      Issue - 12,     Year - 2022


ABSTRACT:
Introduction: The use of chemotherapy over many years has attracted the attention of cancer patients for the treatment or prolongation of significant benefits, but unfortunately, in addition to all the advantages it has, there are consequences. Side effects of chemotherapy in the oral-pink area include inflammation, mouth ulcers, increased prevalence of viral, fungal, bacterial and bleeding infections. These side effects cause significant pain, malnutrition, and even, in some cases, a reduction in the amount of chemotherapy used by the treating physician. The aim of this study was to determine the oral and dental complications caused by cyclophosphamide in patients with breast cancer in the Department of Chemotherapy of Shahid Mostafa Hospital, Ilam Province in 2019. Materials and Method: The present study is an analytical-cross-sectional study performed on patients with breast cancer at Shahid Mostafa Hospital in Ilam in 2019-2020 and a researcher-made questionnaire was used to collect information. Results: The mean age of patients was 8.81±50.89 and their age range was between 36 and 69 years, and the mean body mass index was 2.56±24.18 and the range was between 29-19. All patients were female. 68.1% of dental patients, 20.3% had no dental caries, and 11.6% had no debar. The results showed that 89.9% of the patients had oral and dental complications with the use of silcophosphamide. 44.9% of patients had mild mucositis, none of them had moderate mucositis, and 55.1% had severe mucositis. Significant relationships were also found between dry mouth and the severity of mucositis. Patients with low- and moderate-grade dry mouth with severe mucositis were reported to be 31.3 and 75 percent, respectively. Conclusion: In the case of mucositis, the importance of oral hygiene in cancer patients should be emphasized. Although there is no scientific evidence that oral hygiene plays a role in the prevention and treatment of mucositis, most researchers believe that oral hygiene can reduce the duration and severity of mucositis.


Cite this article:
Mohammad Ali Roozegar, Hassan Nourmohammadi, Mohammadreza Havasian, Hossein Seidkhani, Solmaz Jamdar. Evaluation of Oral and Dental complications caused by Cyclophosphamide in patients with breast cancer in the Shahid-Mostafa Hospital, Ilam, 2019. Research Journal of Pharmacy and Technology2022; 15(12):5517-0. doi: 10.52711/0974-360X.2022.00931

Cite(Electronic):
Mohammad Ali Roozegar, Hassan Nourmohammadi, Mohammadreza Havasian, Hossein Seidkhani, Solmaz Jamdar. Evaluation of Oral and Dental complications caused by Cyclophosphamide in patients with breast cancer in the Shahid-Mostafa Hospital, Ilam, 2019. Research Journal of Pharmacy and Technology2022; 15(12):5517-0. doi: 10.52711/0974-360X.2022.00931   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-12-25


REFERENCES:
1.    WILKES JD. Prevention and treatment of oral mucositis following cancer chemotherapy. In: Seminars in oncology, 1998.
2.    Taheri M, Najafi M, Salehi M. Clinical evaluation of the effects of radiotherapy on oral mucosa and gingival health in radiotherpy center of Ghaem Hospital. Journal of Mashhad Dental School. 2006 Sept 1, 30 (1):87-98.doi.org/10.22038/JMDS.2006.1460
3.    Jayashree V, Malarkodi V. Breast Cancer and various Prognostic Biomarkers for the diagnosis of the disease: A Review. Research Journal of Pharmacy and Technology. 2017 Oct 1. 10(9): 3211-16.‏ doi.org/10.5958/0974-360X.2017.00570.4
4.    Shayan A, Masoumi SZ, Babaei M, Jamshidi F, Alimohamadi N, Havasian MR,  Shobeiri F. Investigation of factors affecting sexual disorders in women with breast cancer. Journal of Pharmaceutical Sciences and Research. 2017 Oct 1; 9(9): 1576-80.‏ doi.org/10.15520/ijcrr/2017/8/05/175
5.    Hariramani N, Jayanthi S. A Systematic Review of Intrinsic Factors and its Influence in Breast Cancer. Research Journal of Pharmacy and Technology. 2018 Dec 1; 11(8): 3543-6.‏ doi.org/10.5958/0974-360X.2018.00654.6  
6.    Alrubaye YSJ, Mohammed MB, Abdulamir HA. Exosome and Breast Cancer. Research Journal of Pharmacy and Technology. 2022 Apr 1; 15(3): 1393-97.‏ doi.org/10.52711/0974-360X.2022.00232
7.    Little JW, Falace DA, Miller CS, Nelson L. Dental management of the medically compromised patient. WB Sunders. Philadelphia. 2002; 6th ed: pp. 387-416.
8.    Eshghyar N, Bateby M .The prevalence of chemotherapy side effects of cancerous patients on oral health. J Dent Med. 2001 July 1; 14(2):32-7.  
9.    Fathieh A, Safaei M. Investigation of the effect of chemotherapy on the oral flora of children with leukemia. University Dental Journal. Tehran University of Medical Sciences and Health Services 2003 Nov 1; 20(3): 336- 43.
10.    Childers NK, Stinnett EA, Wheler P, Wright JT, Castleberry RP, Dasanayake AP. Oral complications in children with cancer. Oral Surg Oral Med Oral Pathol. 1993 Jan 1; 75(1):41-7. https://doi.org/10.1016/0030-4220(93)90404-R
11.    Haslett C, Chilvers ER, Hunter JAA. Davidson's Principles and practice of medicine. UK: Churchill Livingstone. London. 2000; 8th ed: pp. 1056-61.
12.    Mojahed MM, Aghili M , Kazemian A, Farhan F, Izadi Sh. CELECOXIB-Chemoradiation therapy for reducing mucositis and other acute side effects in advance head and neck carcinoma. Tehran Univ Med J. 2009 May 1; 66(11):797-803. http://tumj.tums.ac.ir/article-1-515-en.html
13.    Jishala MI, Venkateswaramurthy N. Sambathkumar R. Cardiotoxicity associated with Cancer Chemotherapy. Research Journal of Pharmacy and Technology. 2020 May 30; 13(5):2480-7.‏ doi: 10.5958/0974-360X.2020.00443.6
14.    Ali AK, AL rikabi AAN. Compartment between Breast Cancer Patient Undergoing Chemotherapy and Healthy Women by Cytokinesis-block Micronucleus testand Nuclear Division Index. Research Journal of Pharmacy and Technology. 2020 Jun 12; 11(2):705-10.‏ doi : 10.5958/0974-360X.2018.00133.6
15.    Hasan MK, Ghareeb MM. Mate BF, Aga QAIAK. Clinical adverse effects of Chemotherapy protocolusing 6-Mercaptopurine in Iraqi patients with Acute Lymphocytic Leukemia during Maintenance Phase. Research Journal of Pharmacy and Technology. 2019 Feb 24; 12(12):57-64.‏ doi : 10.5958/0974-360X.2019.00997.1
16.    Acharya S, Pai KM, Bhat S, Mamatha B, Bejadi VM, Acharya S. Oral changes in patients undergoing chemotherapy for breast cancer. Indian journal of dental research. 2017 May-Jun; 28(3):261-8. doi: 10.4103/ijdr.IJDR_379_16
17.    Otmani N, Alami R, Hessissen L, Mokhtari A, Soulaymani A, Khattab M. Determinants of severe oral mucositis in paediatric cancer patients: a prospective study. Int J Paediatr Dentis. 2011 March 1; 21(3):210-16. doi.org/10.1111/j.1365-263X.2011.01113.x
18.    Ponce-Torres E, Ruíz-Rodríguez MdS, Alejo-González F, Hernández-Sierra JF, Pozos-Guillén Ad. Oral manifestations in pediatric patients receiving chemotherapy for acute lymphoblastic leukemia. J Clin Pediatr Dentis. 2010 June 29; 34(3):275-9. doi.org/10.17796/jcpd.34.3.y060151580h301t7
19.    Maiguma T, Hayashi Y, Ueshima S, Kaji H, Egawa T, Chayama K, et al. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia. Int J Clin Pharmacol Therapeut. 2008 Nov 1; 46(11):584-90. doi.org/10.5414/cpp46584
20.    Jain PK, Gilhotra R, Kori ML. Drug Release and Mucoadhesive behavior of Hydrogel in Chemo-Radiotherapy induced Oral Mucositis. Research Journal of Pharmacy and Technology. 2019 Jan 1; 12(6):2838-46.‏doi.org/10.5958/0974-360X.2019.00478.5
21.    Ali AK, AL-rikabi AAN. Compartment Between Breast Cancer Patient Undergoing Chemotherapy and Healthy Women by Cytokinesis-block Micronucleus testand Nuclear Division Index. Research Journal of Pharmacy and Technology. 2018 June 12; 11(2): 705-10.‏ doi.org/10.5958/0974-360X.2018.00133.6
22.    Poulopoulos A, Papadopoulos P, Andreadis D. Chemotherapy: oral side effects and dental interventions. A review of the literature. Stomatological Dis Sci. 2017 Aug 29; 1(1):35-49. doi.org/10.20517/2573-0002.2017.03
23.    Cheng KK, Chang AM, Yuen MP. Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care. European journal of cancer. 2004 May 1;40(8):1208-16.doi.org/10.1016/j.ejca.2003.10.023
24.    Panahi J, Havasian MR, Roozegar MA. Knowledge of physical education teachers’ toward tooth avulsion in Tehran, Iran. J Oral Health Oral Epidemiol. 2014 Summer; 3(2):66-71. doi.org/10.22122/JOHOE.V7I3.374
25.    Garousian M, Khani S, Shayan A, Taravati M, Babakhani N, Faradmal J, Havasian MR, Masoumi SZ. The effect of cognitive behavioral consultation on marital quality among women. National Journal of Physiology, Pharmacy and Pharmacology. 2018 June 1; 8(4):604-10.‏ doi.org/10.5455/njppp.2018.8.1041904122017
26.    Rahnavardi M, Shayan A, Babaei M, Khalesi ZB, Havasian MR, Ahmadi M.  Investigating types and causes of domestic violence against women and identifying strategies to deal with it from the perspective of victims. Research Journal of Pharmacy and Technology. 2017 October 1; 10(10):3637-42.‏ doi.org/10.5958/0974-360X.2017.00660.6
27.    Otogara M, Babaei M, Abzadeh ZA, Shabanpoor M, Havasian MR. Rad SH, Shayan A. The Effect of Communication Skills Training for Medical Personnel on Patients’ Satisfaction. Research Journal of Pharmacy and Technology. 2017 March 26; 10(11): 3951-6.‏doi.org/10.5958/0974-360X.2017.00717.X
28.    Rask C, Albertioni F, Bentzen SM, Schroeder H, Peterson C. Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia--a logistic regression analysis. Acta oncologica. 1997 Feb 1; 37(3):277-84. doi.org/10.1080/028418698429586
29.    Cheng Kf. Association of plasma methotrate , neutropenia , hepatic dysfunction, nausea / comiting and oral mucositis in children with cancer. Europ J cancer care. 2008 Nov 7; 17(3):306-11. doi.org/10.1111/j.1365-2354.2007.00843.x
30.    Borowski B, Benhamou E, Pico J, Laplanche A, Margainaud J, Hayat M. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Europ J Cancer Part B: Oral Oncol. 1994 Oct 1; 30(2):93-7.doi.org/10.1016/0964-1955(94)90059-0
31.    Rosen LS, Abdi E, Davis ID ,Gutheil J, Schnell FM, Zalcberg J, et al. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol. 2006 Sept 21; 24(33):5194-5200.doi.org/ 10.1200/JCO.2005.04.1152
32.    Rock EP, Kennedy DL, Furness MH, Pierce WF, Pazdur R, Burke LB. Patient-reported outcomes supporting anticancer product approvals. J Clin Oncol. 2007 Sept 21; 25(32):5094-99.doi.org/10.1200/JCO.2007.11.3803
33.    Maiguma T, Hayashi Y, Ueshima S, Kaji H, Egawa T, Chayama K, et al. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia. Int J Clin Pharmacol Therapeut. 2008 Nov 1; 46(11):584-90.doi.org/10.5414/cpp46584
34.    McCarthy G, Awde J, Ghandi H, Vincent M, Kocha W. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol. 1998 Nov 1;34(6):484-90.doi.org/10.1016/S1368-8375(98)00068-2
35.    Chiara S, Nobile MT, Vincenti M, Gozza A, Pastrone I, Rosso M, et al. Sucralfate in the treatment of chemotherapy-induced stomatitis: a double-blind, placebo-controlled pilot study. Anticancer Res. 2000 Sep-Oct; 21(5):3707-10.PMID: 11848548
36.    El–Housseiny A, Saleh S, El–Masry A, Allam A. The effectiveness of vitamin" E" in the treatment of oral mucositis in children receiving chemotherapy. J Clin Pediatr Dentis. 2007 June 3; 31(3):167-70.doi.org/10.17796/jcpd.31.3.r8371x45m42l10j7


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available